Trial Profile
A phase I/II study of margetuximab in gastroesophageal cancer
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 05 Mar 2015
Price :
$35
*
At a glance
- Drugs Margetuximab (Primary)
- Indications Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
- 05 Mar 2015 New trial record
- 03 Mar 2015 MacroGenics plans to initiate this study in the fourth quarter of 2015.